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Abstract
Reliable, comparable information about the main causes of disease and injury in populations, and
how these are changing, is a critical input for debates about priorities in the health sector.
Traditional sources of information about the descriptive epidemiology of diseases, injuries and risk
factors are generally incomplete, fragmented and of uncertain reliability and comparability. Lack of
a standardized measurement framework to permit comparisons across diseases and injuries, as
well as risk factors, and failure to systematically evaluate data quality have impeded comparative
analyses of the true public health importance of various conditions and risk factors. As a
consequence the impact of major conditions and hazards on population health has been poorly
appreciated, often leading to a lack of public health investment. Global disease and risk factor
quantification improved dramatically in the early 1990s with the completion of the first Global
Burden of Disease Study. For the first time, the comparative importance of over 100 diseases and
injuries, and ten major risk factors, for global and regional health status could be assessed using a
common metric (Disability-Adjusted Life Years) which simultaneously accounted for both
premature mortality and the prevalence, duration and severity of the non-fatal consequences of
disease and injury. As a consequence, mental health conditions and injuries, for which non-fatal
outcomes are of particular significance, were identified as being among the leading causes of
disease/injury burden worldwide, with clear implications for policy, particularly prevention. A
major achievement of the Study was the complete global descriptive epidemiology, including
incidence, prevalence and mortality, by age, sex and Region, of over 100 diseases and injuries.
National applications, further methodological research and an increase in data availability have led
to improved national, regional and global estimates for 2000, but substantial uncertainty around the
disease burden caused by major conditions, including, HIV, remains. The rapid implementation of
cost-effective data collection systems in developing countries is a key priority if global public policy
to promote health is to be more effectively informed.
Introduction
Whether it is through scientific curiosity, administrative
edict or public health planning necessity, most countries
have initiated some form of data collection and health
surveillance/monitoring systems to provide information
on health priorities. In some cases, such as the Bills of
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Mortality of the London Parishes, these attempts date
back well over 300 years [1]. Cause of death statistics for
the population of England and Wales have been collected
for almost 200 years, and in most developed countries, for
at least a century [2]. Further, many developed countries
have instituted incidence registers for major diseases of
public health importance, such as cancer, or routinely
conduct health surveys to measure the prevalence of dis-
ease or risk factor exposures [3,4]. In poorer countries,
national registration and certification of all deaths is less
common, due to the cost of establishing and maintaining
such a system, and often the mortality data collected are
incomplete and of poor quality [5]. 'Verbal autopsy' pro-
cedures, using structured interviews with the family of the
deceased, provide a history of symptoms experienced by
the deceased, but translating these into reliable cause of
death information for populations has only met with lim-
ited success [6-9]. Moreover, reliable information on the
incidence and prevalence of diseases, injuries and risk fac-
tors is rarely available in developing countries, and what
data are collected, particularly hospital records, are
unlikely to reflect the true pattern of disease and injury in
the community due to biases arising from the nature of
conditions typically treated in hospitals and the ability of
sectors of the population to afford tertiary care.
As a result, while most countries have some information
about prevalence, incidence and mortality from some dis-
eases and injuries, and some information on population
exposure to risk factors, it is generally fragmented, partial,
incomparable and diagnostically uncertain. Setting health
priorities, however, requires, or at least should, informa-
tion that is comparable, reliable and comprehensive
across a wide range of conditions and exposures that cause
death or ill-health in a population. The importance of
capturing disease burden from largely non-fatal, but prev-
alent conditions such as depression or musculoskeletal
conditions is critical. Substantial resources are usually
invested by society to reduce their impact in populations,
yet they rank extremely low among causes of mortality,
the traditional basis upon which health priorities have
been considered.
This paper describes a framework (the Global Burden of
Disease Study [10]) for integrating, validating, analysing
and disseminating fragmentary information on the health
of populations so that it is truly useful for health policy
and planning. Features of this framework include the
incorporation of data on non-fatal health outcomes into
summary measures of population health, the develop-
ment of methods and approaches to estimate missing data
and to assess the reliability of data, and the use of a com-
mon metric to summarise disease burden from both diag-
nostic categories of the International Classification of
Disease and Injuries, and the major risk factors that cause
those health outcomes. The approach has been widely
adopted by countries and health development agencies
alike as the standard for health accounting, as well as
guiding the determination of health research priorities
[11-14].
Global Burden of Disease 1990 Study
The Global Burden of Disease (GBD) Study was commis-
sioned by The World Bank in the early 1990s to provide a
comprehensive assessment of disease burden in 1990
from over 100 diseases and injuries, and from 10 selected
risk factors, for the world and 8 major World Bank regions
[15-17]. The estimates were combined with research into
the cost-effectiveness of intervention choices in different
populations to develop recommended intervention pack-
ages for countries at different stages of development [18].
The methods and findings of the original (1990) GBD
Study have been widely published [18-25], and have
spawned numerous national disease burden exercises.
The basic philosophy guiding the burden of disease
approach is that there is likely to be information content
in almost all sources of health data, provided they are
carefully screened for plausibility and completeness; and
that internally consistent estimates of the global descrip-
tive epidemiology of major conditions are possible with
appropriate tools, investigator commitment and expert
opinion. To prepare estimates of the incidence, preva-
lence, duration and mortality from over 500 sequelae of
more than 100 disease or injuries, a mathematical model,
DISMOD, was developed for the 1990 GBD Study to con-
vert partial, often non-specific data on disease/injury
occurrence into a consistent age description of the basic
epidemiological parameters in each Region [26].
To assess disease burden, a time-based metric which
measured both premature mortality (years of life lost, or
YLLs) and disability (years of life lived with a disability,
weighted by the severity of the disability, or YLDs) was
used. The sum of the two components, namely Disability-
Adjusted Life Years, or DALYs, provides a measure of the
future stream of healthy life (i.e. years expected to be lived
in full health) lost as a result of the incidence of specific
diseases and injuries in 1990. The effect of incident fatal
cases (of disease or injury) is captured by YLLs, while the
future health consequences, in terms of sequelae of dis-
eases or injuries, of incident cases in 1990 that were not
fatal, are measured by YLDs. A more complete account of
the index, and the philosophy underlying parameter
choices, is described elsewhere [27,28]. DALYs are not
unique to the Global Burden of Disease Study. A variant of
DALYs was used by The World Bank in the seminal Health
Sector Priorities Review study [29], and derive more gen-
erally from earlier work to develop time-based measures
that better reflect the public health impact of death or ill-
ness at younger ages [30,31]. DALYs are a particularGlobalization and Health 2005, 1:5 http://www.globalizationandhealth.com/content/1/1/5
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(inverse) form of the more general concept of "Quality-
Adjusted Life Years" or QALYs, proposed by Zeckhauser
and Shepard in 1976 [32] and widely used in economic
evaluations. Much of the comment and criticism of the
GBD Study has focussed on the construction of DALYs
[33-35], particularly the social choices around age-
weights and severity scores for disabilities, and relatively
little around the vast uncertainty of the basic descriptive
epidemiology, especially in Africa, which is likely to be far
more consequential for setting health priorities [36].
The results of the study confirmed what many health
workers in mental health promotion and injury preven-
tion had suspected for some time, namely that neuropsy-
chiatric disorders on the one hand, and injuries on the
other, were major causes of lost years of healthy life, as
measured by DALYs. Table 1 summarises the major causes
of disease burden worldwide in 1990 from among the 100
or so specific conditions quantified in the Study. The
Table also lists the leading causes of premature mortality,
as well as disability, as measured by YLLs and YLDs,
respectively. Globally, in 1990, the leading causes of
childhood diseases (lower respiratory diseases, diarrhoeal
diseases, and perinatal causes such as birth asphyxia, birth
traumas and low birth weight) were also the leading
causes of disease burden, in part because of their concen-
tration at younger ages. Interestingly, depression ranked
fourth, ahead of ischaemic heart disease, cerebrovascular
disease, tuberculosis and measles. Road traffic accidents
also ranked in the top 10 causes of DALYs worldwide.
Using more broad disease categories, non-communicable
diseases, including neuropsychiatric disorders, were esti-
mated to have caused 41% of the global burden of disease
in 1990, only slightly less than communicable, maternal,
perinatal and nutritional conditions combined (44%),
with 15% due to injuries [10]. The class of infectious and
parasitic diseases were the cause of more than one in five
(23%) DALYs lost in 1990, followed by neuropsychiatric
conditions (10.5%), cardiovascular diseases (9.7%), res-
piratory infections (8.5%), perinatal conditions (6.7%)
and cancers (5.1%).
By and large, the leading causes of years of potential life
lost (YLLs) were similar, the major difference being that
depression is not a major cause of premature mortality. It
is, however, a major cause of non-fatal disease burden,
causing more than 10% of all years lived with a disability
(YLDs) worldwide, more than twice the contribution
from the next leading cause, anaemia (4.7%). Indeed, as
Table 1 shows, five of the top 10 leading causes of disabil-
ity in 1990, as measured by YLDs, were neuropsychiatric
conditions.
For prevention, comparative estimates of the disease and
injury burden caused by exposure to major risk factors is
likely to be a much more useful guide to policy action and
priorities than a 'league table' of disease and injury burden
alone. Over the past few decades, epidemiologists have
attempted to quantify the impact of specific exposures,
particularly tobacco, on mortality, either from major dis-
eases such as cancer [37,38], or across a group of countries
using comparable methods [39,40]. Specific country stud-
ies have examined the impact of several leading risk fac-
tors [41,42], but prior to the GBD Study, there was no
Table 1: Leading causes of premature mortality, disability and disease burden, World, 1990
Premature Mortality Disability Disease Burden
Rank Disease/ injury YLLs 
(000s)
Cumulative % Disease/injury YLDs 
(000s)
Cumulative% Disease/injury DALYs 
(000s)
% of 
Total
1 Lower res. inf. 108601 12.0 Depression 50810 10.7 Lower res. inf. 112898 8.2
2 Diarrhoeal dis. 94434 22.4 Iron def. anaem. 21987 15.4 Diarrhoeal dis. 99633 7.2
3 Perinatal cond. 82681 31.5 Falls 21949 20.0 Perinatal cond. 92313 6.7
4 Isch. heart dis. 41595 36.1 Alcohol use 15770 23.4 Depression 50810 3.7
5 Measles 36450 40.1 COPD1 14692 26.5 Isch. heart dis. 46699 3.4
6 Tuberculosis 34304 43.9 Bipolar dis. 14141 29.5 Cerebrovas. dis. 38523 2.8
7 Cerebrovas. Dis. 32115 47.5 Congenital anom 13507 32.3 Tuberculosis 38426 2.8
8 Malaria 28038 50.5 Osteoarthritis 13275 35.1 Measles 36520 2.7
9 Road traffic acc. 26162 53.4 Schizophrenia 12183 37.7 Road traffic acc. 34317 2.5
10 Congenital anom. 19414 55.6 Obs.-comp dis2 10213 39.9 Congenital anom. 32921 2.4
Source Murray and Lopez (10)
1 Chronic obstructive pulmonary disease
2 Obsessive-compulsive disordersGlobalization and Health 2005, 1:5 http://www.globalizationandhealth.com/content/1/1/5
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global assessment of the fatal and non-fatal disease and
injury burden from exposure to major health hazards. Ten
such hazards (see Table 2) were quantified in the 1990
Study, based on information about causation, prevalence,
exposure, and disease and injury outcomes available at
the time. Almost one-sixth of the entire global burden of
disease and injury that occurred in 1990 was attributed to
malnutrition, another 7% or so to poor water and sanita-
tion, and 2–3% from risks such as unsafe sex, tobacco,
alcohol and occupational exposures.
Improving Comparative Quantification of 
Diseases, Injuries and Risk Factors: The Global 
Burden of Disease 2000 Study
The initial Global Burden of Disease Study represented a
quantum leap in the global and regional quantification of
the impact of diseases, injuries and risk factors on popula-
tion health. The results of the study have been widely used
by government and non-governmental agencies alike to
argue for more strategic allocation of health resources to
disease prevention and control programs that are likely to
yield the greatest gains in population health. Following
the publication of the initial study, several national appli-
cations of the methods have led to substantially more data
on the descriptive epidemiology of diseases and injuries,
as well as to improvements in analytical methods. Cri-
tiques of the approach, and particularly of the methods
used to assess the severity weightings for disabling health
states, have led to fundamental changes in the way that
health state valuations are determined (population-based
rather than expert opinion as used in the 1990 study), and
to substantially better methods for improving the cross-
national comparability of survey data on health status
[43,44]. Better methods for modelling the relationship
between the level of mortality and the broad cause struc-
ture in populations, based on proportions rather than
rates, have led to greater confidence in cause of death esti-
mates for developing countries [45]. Improved popula-
tion surveillance for some major diseases such as HIV/
AIDS, and the wider availability of data from 'verbal
autopsy' methods, particularly in Africa, has lessened the
dependence on models for cause of death estimates,
although substantial uncertainty still remains in the use of
such data.
Perhaps the major methodological progress since the
GBD 1990 Study has been with respect to risk-factor
quantification. In the initial study, the population health
effects of 10 risk factors were quantified, but there are
serious concerns about the comparability of the estimates.
Different risk factors have very different epidemiological
traditions, particularly with regard to the definition of
"hazardous" exposure, the strength of evidence on causal-
ity, and the availability of epidemiological research on
exposure and outcomes. As a result, comparability across
estimates of disease burden due to different risk factors is
difficult to establish. Moreover, classical risk factor
research has treated exposures as dichotomous, with indi-
viduals either exposed or non-exposed, with exposure
defined according to some, often arbitrary, threshold
value. Recent evidence for such continuous exposures as
cholesterol, blood pressure and body mass index suggests
that such arbitrarily defined thresholds are inappropriate,
since hazard functions for these risks decline continu-
ously across the entire range of measured exposure levels,
with no obvious threshold [46,47] For the GBD 2000
Study, a new framework for risk factor quantification was
defined which, instead of the classical dichotomous
approach, measured changes in disease burden that
would be expected under different population distribu-
tions of exposure [48] Attributable fractions of disease
due to a risk factor were then calculated based on a com-
Table 2: Global burden of disease and injury attributable to selected risk factors, 1990
Risk factor Deaths 
(thousands)
As % 
of total 
deaths
YLLs 
(thousands)
As % 
of total 
YLLs
YLDs 
(thousands)
As % of 
total YLDs
DALYs 
(thousands)
As % of 
total 
DALYs
Malnutrition 5 881 11.7 199 486 22.0 20 089 4.2 219 575 15.9
Poor water supply sanitation 
and personal and domestic 
hygiene
2 668 5.3 85 520 9.4 7 872 1.7 93 392 6.8
Unsafe sex 1 095 2.2 27 602 3.0 21 100 4.5 48 702 3.5
Tobacco 3 038 6.0 26 217 2.9 9 965 2.1 36 182 2.6
Alcohol 774 1.5 19 287 2.1 28 400 6.0 47 687 3.5
Occupation 1 129 2.2 22 493 2.5 15 394 3.3 37 887 2.7
Hypertension 2 918 5.8 18 665 1.9 1 411 0.3 19 076 1.4
Physical inactivity 1 991 3.9 11 353 1.3 2 300 0.5 13 653 1.0
Illicit drugs 100 0.2 2 634 0.3 5 834 1.2 8 467 0.6
Air pollution 568 1.1 5 625 0.6 1 630 0.3 7 254 0.5
Source: Murray and Lopez (10)Globalization and Health 2005, 1:5 http://www.globalizationandhealth.com/content/1/1/5
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parison of disease burden expected under the current (i.e.
2000) estimated distribution of exposure, by age, sex and
Region, with that expected if a counterfactual distribution
of exposure had applied. The counterfactual distribution
was defined for each risk factor as the population distribu-
tion of exposure that would lead to the lowest theoretical
minimum levels of disease burden. Thus, for example, in
the case of tobacco, the theoretical minimum distribution
would be 100% of the population being life-long non-
smokers; for BMI it would be 100% of the population
having a BMI of 21 (SD1) kg/m2, and so on. The theoret-
ical minima for each of the risk factors quantified in the
WHO Comparative Risk Assessment (CRA) study (the risk
factor arm of the GBD 2000 Study) were developed by
expert groups for each risk factor and are described in
more detail elsewhere [49,50].
The main findings of the CRA Study are summarized in
Table 3. In all, 26 risk factors were quantified, each by age
and sex, and within 14 WHO epidemiological Regions, as
well as for the world. These regions were further grouped
into "developed" "low-mortality developing" including
China and much of Latin America, and "high mortality
developing" including Sub-Saharan Africa, and many
countries in Western and Southern Asia, including India,
Bangladesh and Myanmar. As the table suggests, the world
is currently experiencing a "risk factor" transition, with
developed countries characterized by high disease burden
from tobacco, sub-optimal blood pressure, alcohol, cho-
lesterol and overweight. Disease burden in the poorest
countries, on the other hand, is primarily caused by
underweight, unsafe sex, unsafe water and sanitation,
indoor air pollution and micronutrient deficiencies (zinc,
iron, vitamin A). Interestingly, the risk factors which, on
average, cause the greatest disease burden among the 2.4
billion people living in low-mortality developing coun-
tries are a mixture of both, led by alcohol, sub-optimal
blood pressure and tobacco, followed by underweight
and overweight. This juxtaposition of what might be
termed "new" and "old" risk factors strongly suggests that
health policy in developing countries must increasingly
address risks such as tobacco and blood pressure that have
often mistakenly been labelled, and treated, as conditions
of affluence.
Improving Cross-Population Comparability of 
Disease Burden Assessments
While the first Global Burden of Disease Study set new
standards for measuring population health, the basic
units of analysis for the study were the 8 World Bank
Table 3: Leading risk factors for disease burden in 2000, by development category
Developing countries Developed countries
High mortality countries % of Total DALYs % of Total DALYs
Underweight 14.9% Tobacco 12.2%
Unsafe sex 10.2% Blood pressure 10.9%
Unsafe water, sanitation and hygiene 5.5% Alcohol 9.2%
Indoor smoke from solid fuels 3.6% Cholesterol 7.6%
Zinc deficienty 3.2% Overweight 7.4%
Iron deficiency 3.1% Low fruit and vegetable intake 3.9%
Vitamin A deficiency 3.0% Physical inactivity 3.3%
Blood pressure 2.5% Illicit drugs 1.8%
Tobacco 2.0% Unsafe sex 0.8%
Cholesterol 1.9% Iron deficiency 0.7%
Low mortality countries % of Total DALYs
Alcohol 6.2%
Blood pressure 5.0%
Tobacco 4.0%
Underweight 3.1%
Overweight 2.7%
Cholesterol 2.1%
Low fruit and vegetable intake 1.9%
Indoor smoke from solid fuels 1.9%
Iron deficiency 1,8%
Unsafe water, sanitation and hygiene 1.8%
Source: World Health Organization (46)Globalization and Health 2005, 1:5 http://www.globalizationandhealth.com/content/1/1/5
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Regions defined for the 1993 World Development Report.
Designed to be geographically contiguous, these Regions
were nonetheless extremely heterogenous with respect to
health development. Other Asia and Islands (OAI) for
example, included countries with such diverse epidemio-
logical profiles as Singapore and Myanmar. This seriously
limits their value for comparative epidemiological assess-
ments. For the Global Burden of Disease 2000 Study, a more
refined approach was followed. Estimates of disease and
injury burden were first developed for each individual
Member State of WHO (191 in 2000) using different
methods for countries at different stages of health devel-
opment, often largely determined by the availability of
data [51]. For example, age-sex-specific death rates for
countries were essentially determined using one of three
standard approaches: routine life-table methods for coun-
tries with complete vital registration; application of stand-
ard demographic methods to correct for under-
registration of deaths; or, where no vital registration data
on adult mortality were available, application of model
life tables [51,52].
The detailed methodological approaches adopted for
countries to estimate cause-specific mortality, and the
descriptive epidemiology of non-fatal conditions in each
country are described elsewhere [53]. This focus on indi-
vidual countries as the unit of analysis, as well as the sys-
tematic application of standardized approaches for all
countries in any given category of data availability, has
vastly improved the cross- population comparability of
disease and injury quantification, at least among coun-
tries at similar levels of health development.
Caution is required, however, in inferring comparability
of national disease burden assessments across countries at
different levels of development. Estimates of mortality in
countries where there is no functioning vital registration
system for causes of death will always be substantially
more uncertain than those derived from systems where all
deaths are registered and medically certified, as is the case
for developed countries. For example, in the United
States, uncertainty around the mean life expectancy for
males in 2000 (73.9 years) was ± 0.3 years, compared to ±
3.5 years in Uganda [51]. The same may be said for the
quantification of disability due to various conditions,
where the gap in data availability between rich and poor
countries is likely to be even more extreme than for mor-
tality. A major advance with the Global Burden of Disease
2000 Study has been the systematic attempt to quantify
uncertainty in both national and global assessments of
disease burden. This uncertainty must be taken into
account when making cross-national comparisons, and
needs to be carefully communicated and interpreted by
epidemiologists and policy makers alike.
To date, systematic national estimates of the burden of
disease due to major risk factors, applying the
standardized framework of the Comparative Risk Assess-
ment Project, have not been attempted. Standardized
approaches to measuring mortality attributable to some
risk factors, such as tobacco, have been developed and
applied to 50 or so developed countries [39], but more
research is urgently needed to prepare comparative risk
estimates, by country, using the broader, more compre-
hensive CRA framework. There is no a priori reason to
expect that the uncertainties in cross-national compari-
sons for risk factors would be any greater than those for
diseases and injuries that have already been quantified.
Discussion and Conclusions
The World Development Report 1993 provided an enormous
impetus to the development of global and regional quan-
tification of disease and injury burden, and of what causes
it. The vast exercise in global descriptive epidemiology
that was required to develop estimates led to the first ever
comprehensive estimates of the fatal and non-fatal bur-
den for over 100 diseases and injuries, as well as for
selected risk factors. The development and widespread
application of a single summary measure of population
health (DALYs) has greatly facilitated scientific and polit-
ical assessments of the comparative importance of various
diseases, injuries and risk factors, particularly for priority-
setting in the health sector, and has led to strategic deci-
sions by some agencies eg. WHO, to invest greater effort
in program developments to address priority health con-
cerns such as tobacco control and injury prevention. The
subsequent Global Burden of Disease 2000 Study, and a
plethora of country applications, have led to substantial
improvements in both methods and data availability, as
well as in the comparability of results. They have not,
however, led to significant changes in the comparative
magnitude of most conditions, the single exception being
HIV/AIDs, largely as a result of the explosion of the epi-
demic during the 1990s in Southern Africa. Nor have
these methodological advances adequately addressed the
challenges that arise from new data sets becoming availa-
ble. For example, better methods are needed to estimate
adult mortality levels from survey data [54], to estimate
biases in using hospital data to infer community-level
cause of death patterns, and to more reliably quantify the
joint effects of multiple risks acting in concert to produce
disease outcomes.
This relative stability in the outcomes of disease and risk
factor quantification does not necessarily inspire greater
confidence that the estimates are correct. Rather, it sug-
gests that despite the progress of the past decade, the
incremental gains in advancing our knowledge and
understanding of global descriptive epidemiology have
been modest. There is an urgent need for a globally-coor-Globalization and Health 2005, 1:5 http://www.globalizationandhealth.com/content/1/1/5
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dinated research and development effort to devise and
implement cost-effective approaches to data collection
and analysis in poor countries that is targeted to their
health development needs, and that can routinely yield
comparable information of sufficient quality to establish
how disease and risk factor burden is changing in popula-
tions. Recent calls for the establishment of a global health
monitoring Centre to continuously assess, using compa-
rable methods, the impact of diseases, injuries and risk
factors worldwide are a step in this direction [55], but
much more needs to be done to assist countries with the
development of minimal health information systems. It is
lamentable how little is reliably known about the global
impact of diseases, injuries and risk factors. It would be
unconscionable if we were to be similarly ignorant 10 to
20 years hence.
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